Volume 10, Issue 27 (Jun 2000)                   J Mazandaran Univ Med Sci 2000, 10(27): 48-53 | Back to browse issues page

XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Baba Mahmoodi F. Evaluation of Hepatitis B Antibody (HBS) Levels in Nursing Staff Of Gaemshahr Razi Hospital and it’s Variation With Duration Of Immunity Post HB Vaccination. . J Mazandaran Univ Med Sci 2000; 10 (27) :48-53
URL: http://jmums.mazums.ac.ir/article-1-300-en.html
Abstract:   (40619 Views)
Background and Purpose : The prevalence of Hepatitis B in ÜSÂ was reported 0.5- 0.1 % while in Ïran is 1.6- 6.5 %. Ït was reported that the titer of antibody three days after vaccination was 79-90 %. The titer of antibody decreases with the pass of time, and age has a significant role in the respones to vaccination. This study was performed in order to evaluate the HBS titer after vaccination against hepatitis and the rate of its decline as time passes in the nursing staff of Gaemshahr Razi Hospital.
Materials and Methods: This was a Çross- sectional study, done on 183 nursing staff. 4cc blood was collected from each person at the same time vaccination was repeated. The history of vaccination was reported in a questionnaire paper by the same candidate. HBSÂg and HBSÂb were measured quantitatively with using Ëuro kit by ËLÏSÂ method.
Results: 1.6 % of staff were HBSÂg positive. 54.1%, 13.1% and 10.9% staff received vaccine three times, two times and once and 86%, 71% and, 55% of them had antibody titer more than 10 mu/ml respectively. 21.9% of them were not vaccinated, but 12.5% of them had antibody titer more than 10 mu/ml as time pass there was a decline in antibody titer. So that 94.1% of them in the first year declined to 67.8% in the next fifth year and the age above 40 years had a negative effect on antibody formation.
Çonclusion: Ôld age and numbers of vaccinations has a significant role in the responses to vaccine, and with time the titer of HBS antibody declines, so a booster dose should be considered.
Full-Text [PDF 130 kb]   (3109 Downloads)    
Type of Study: Research(Original) |

Add your comments about this article : Your username or Email:
CAPTCHA

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2025 CC BY-NC 4.0 | Journal of Mazandaran University of Medical Sciences

Designed & Developed by : Yektaweb